These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27712593)

  • 21. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
    Huang S; Jin A
    J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP-9/PI3K/AKT pathway.
    Chen H; Pan R; Li H; Zhang W; Ren C; Lu Q; Chen H; Zhang X; Nie Y
    Cell Biol Int; 2021 Mar; 45(3):623-632. PubMed ID: 33245175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
    Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
    Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
    Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
    Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
    J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
    Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
    Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
    Han Y; Zhao X; Sun Y; Sui Y; Liu J
    J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
    Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway.
    Zhang Y; Weng Q; Han J; Chen J
    Mol Med Rep; 2020 Feb; 21(2):675-684. PubMed ID: 31974628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated LEPRE1 correlates with poor outcome and its knockdown attenuates cells proliferation, migration and invasion in osteosarcoma.
    Huang Z; Wang Q; Wang Y; Zhao L; Cao Z; Cui C; Yu D; Liu B
    Anticancer Drugs; 2020 Apr; 31(4):326-332. PubMed ID: 32197005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proanthocyanidin B2 inhibits proliferation and induces apoptosis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Wu X; Yu H; Zhou H; Li Z; Huang H; Xiao F; Xu S; Yang Y
    J Cell Mol Med; 2020 Oct; 24(20):11960-11971. PubMed ID: 32914567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBE2T knockdown inhibits gastric cancer progression.
    Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
    Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.
    Zhao X; Fang Y; Wang X; Yang Z; Li D; Tian M; Kang P
    Int J Oncol; 2020 Jan; 56(1):206-218. PubMed ID: 31746363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lupeol suppresses migration and invasion
    Hsu MJ; Peng SF; Chueh FS; Tsai CH; Tsai FJ; Huang CY; Tang CH; Yang JS; Hsu YM; Huang WW; Chung JG
    Biosci Biotechnol Biochem; 2019 Sep; 83(9):1729-1739. PubMed ID: 31010399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
    Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
    Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
    Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
    Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Yang B; Wang B; Wang G; Cao W; Wang Q; Pu H; An W
    Anticancer Agents Med Chem; 2023; 23(13):1577-1586. PubMed ID: 37139674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway.
    Da W; Tao L; Zhu Y
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.